Titan Biotech Limited
Titan Biotech Limited
Share · INE150C01011 (XBOM)
Overview
No Price
Closing Price XBOM 27.10.2025: 1.142,90 INR
27.10.2025 09:45
Current Prices from Titan Biotech Limited
ExchangeTickerCurrencyLast TradePriceDaily Change
XBOM: MSE
MSE
TITANBIO.BO
INR
27.10.2025 09:45
1.142,90 INR
-23,30 INR
-2,00 %
Share Float & Liquidity
Free Float 32,08 %
Shares Float 2,65 M
Shares Outstanding 8,26 M
Company Profile for Titan Biotech Limited Share
Titan Biotech Ltd. is a holding company, which engages in manufacturing and exporting of biological products used in the field of Pharmaceutical, Nutraceutical, Food & Beverages, Biotechnology & Fermentation, Cosmetic, Veterinary & Animal Feed, Agriculture Industries, Microbiology Culture Media & Plant Tissue Culture Media. The company was founded on February 18, 1992 and is headquartered in New Delhi, India.
Get up to date insights from finAgent about Titan Biotech Limited

Company Data

Name Titan Biotech Limited
Company Titan Biotech Limited
Website http://www.titanbiotechltd.com
Primary Exchange XBOM MSE
ISIN INE150C01011
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Naresh Kumar Singla
Market Capitalization 4 Mrd.
Country India
Currency INR
Employees 0,4 T
Address 903-909, Bigjos Tower, New Delhi
IPO Date 2000-11-30
Dividends from 'Titan Biotech Limited'
Ex-Date Dividend per Share
19.09.2025 2,00 INR

Ticker Symbols

Name Symbol
MSE TITANBIO.BO
More Shares
Investors who hold Titan Biotech Limited also have the following shares in their portfolio:
CIBANCO S.A. 21/31 REGS
CIBANCO S.A. 21/31 REGS Bond
LB.HESS.-THR. OMH 17/27
LB.HESS.-THR. OMH 17/27 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025